Affiliation:
1. V.A. Nasonova Research Institute of Rheumatology;
The Far Eastern State Medical University
2. Endocrinology Research Centre
3. V.A. Nasonova Research Institute of Rheumatology
Abstract
BACKGROUND: It has been suggested that the presence of chronic immunoinflammatory rheumatic disease (CIRD) may be a factor that increases the likelihood of developing hypogonadism syndrome, and conversely, the presence of uncompensated testosterone deficiency may predispose to a greater risk of developing or more severe course of ICRD.AIM: To study the incidence of hypogonadism in men with rheumatoid arthritis (RA) and evaluate its impact on the course of RA and concomitant diseases.MATERIALS AND METHODS: A one-time continuous study included 170 men with RA who were undergoing inpatient treatment at the Federal State Budgetary Institution NIIR named after. V.A. Nasonova. Patients were assessed for total testosterone levels and subsequently divided into subgroups with normal (>12 nmol/l) and reduced levels. An intergroup comparison was carried out on the main indicators used in clinical rheumatological practice to assess the stage, activity and other medical and demographic characteristics of RA, as well as the state of purine and carbohydrate metabolism. A correlation analysis was performed between the level of total testosterone and some clinical and laboratory parameters.RESULTS: The frequency of detected testosterone deficiency in the study group was 24.1%. Significant correlations were noted between the level of total testosterone and body mass index (r=-0.29), the level of blood uric acid (r=-0.19) and C-reactive protein (r=-0.18). Patients with hypogonadism compared to the group with normal testosterone levels were characterized by higher body mass index (29.3±5.6 vs 26.3±4.0 kg/m2; p<0.001), glucose levels (6.95±7 .85 mmol/l vs 5.42±1.13 mmol/l; p=0.034) and uric acid (354.6±110.7 vs 317.5±84.8 µmol/l; p=0.03) blood. In addition, patients with hypogonadism were more likely to suffer from obesity (41.6% vs 15.7%; p=0.001) and diabetes mellitus (21.6% vs 10.2%; p=0.075) without a statistically significant difference, and also had higher ESR (46.5±42.2 vs 31.0±30.9 mm/h; p=0.012). A more frequent occurrence of anemia was noted in hypogonadism (32.4% vs 16.7%; p=0.041).CONCLUSION: Testosterone levels and the presence of hypogonadism were not associated with the stage and activity of RA, however, testosterone deficiency was accompanied by a more frequent development of overweight and obesity, and a deterioration in purine and carbohydrate metabolism.
Publisher
Endocrinology Research Centre
Reference15 articles.
1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023-2038. doi: https://doi.org/10.1016/S0140-6736(16)30173-8
2. Smolen JS, Landewe RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685-99. doi: https://doi.org/10.1136/annrheumdis-2019-216655
3. Gordeev AV, Matyanova EV, Olyunin YuA, et al. Difficult-to-treat rheumatoid arthritis in the clinical practice of a rheumatological hospital. First look. Modern Rheumatology Journal. 2022;16(2):13-20. (In Russ.) doi: https://doi.org/10.14412/1996-7012-2022-2-13-20
4. Dedov II, Mokrysheva NG, Melnichenko GA, et al. Draft of Russian clinical practice guidelines «Male hypogonadism». Obesity and metabolism. 2021;18(4):496-507 doi: https://doi.org/10.14341/omet12817
5. Panevin TS, Rozhivanov RV, Nasonov EL. Hypogonadism syndrome in men with inflammatory joint diseases: A review. Terapevticheskii Arkhiv (Ter. Arkh.). 2023;95(5):429–433 (In Russ.) doi: https://doi.org/10.26442/00403660.2023.05.202199